Civitas Therapeutics Investors

26 investors on Angel Roster list Civitas Therapeutics in their portfolio. Most are venture capital firms and private equity firms, the most common stage is Seed and the largest groups are based in the United States and Canada.

Investors are matched on the company name in their portfolio, so companies that share the name Civitas Therapeutics can appear together.

Investors listed
26
With verified email
50%
Most common stage
Seed
Top location
United States

Updated October 13, 2026 · How we compile this data

Top 26 Civitas Therapeutics investors

The most complete profiles first. Showing 26 of 26.

  • Amar PatelVerified

    Venture Capital, Investor · United States

    SeedHealth CareWearablesWomen FoundedLife Science

    Portfolio: Zavante Therapeutics, CardioDx, WelbeHealth, Velicept Therapeutics and 52 more

    Verified email available

  • Brian LiuVerified

    Venture Capital, Private Equity Firm, Investor · United States

    SeedHealth CareWearablesWomen FoundedLife Science

    Portfolio: Zavante Therapeutics, CardioDx, WelbeHealth, Velicept Therapeutics and 52 more

    Verified email available

  • Jonathan LeffVerified

    Venture Capital, Investor · United States

    SeedSeries BHealth CareGeneticsWomen FoundedLife Science

    Portfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 66 more

    Verified email available

  • Karthik BolisettyVerified

    Venture Capital, Investor · United States

    SeedHealth CareWearablesWomen FoundedLife Science

    Portfolio: Zavante Therapeutics, CardioDx, WelbeHealth, Velicept Therapeutics and 52 more

    Verified email available

  • Michael WertVerified

    Venture Capital, Private Equity Firm, Investor · United States

    SeedHealth CareWearablesWomen FoundedLife Science

    Portfolio: Zavante Therapeutics, CardioDx, WelbeHealth, Velicept Therapeutics and 52 more

    Verified email available

  • Sarah BhagatVerified

    Venture Capital, Investor · United States

    SeedHealth CareGeneticsWomen FoundedLife Science

    Portfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 63 more

    Verified email available

  • Sonia ParekhVerified

    Venture Capital, Investor · United States

    SeedHealth CareWearablesWomen FoundedLife Science

    Portfolio: Zavante Therapeutics, CardioDx, WelbeHealth, Velicept Therapeutics and 52 more

    Verified email available

  • Alan ColowickVerified

    Venture Capital · United States

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 63 more

    Verified email available

  • David BeierVerified

    Venture Capital · United States

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: Dermira, Phenomix, NuPathe, Cydan and 52 more

    Verified email available

  • Garrett HowardVerified

    Venture Capital · United States

    Health CareWearablesWomen FoundedLife Science

    Portfolio: Zavante Therapeutics, CardioDx, WelbeHealth, Velicept Therapeutics and 52 more

    Verified email available

  • Jason PittsVerified

    Venture Capital · United States

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 63 more

    Verified email available

  • Josh RichardsonVerified

    Venture Capital · United States

    Health CareWearablesWomen FoundedLife Science

    Portfolio: Zavante Therapeutics, CardioDx, WelbeHealth, Velicept Therapeutics and 52 more

    Verified email available

  • Mike PowellVerified

    Venture Capital · United States

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 63 more

    Verified email available

  • Maha Katabi, PhD, CFA

    Hedge Fund, Venture Capital, Investor · Canada

    SeedHealth CareGeneticsWomen FoundedInvestment Management

    Portfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 64 more

    Contact details available

  • Maxwell Bikoff

    Venture Capital, Private Equity Firm, Investor · United States

    SeedHealth CareWearablesWomen FoundedLife Science

    Portfolio: Zavante Therapeutics, CardioDx, WelbeHealth, Velicept Therapeutics and 52 more

    Contact details available

  • Perry Nisen

    Venture Capital, Investor · United States

    SeedHealth CareGeneticsWomen FoundedLife Science

    Portfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 63 more

    Contact details available

  • Alfred Yue

    Venture Capital · United States

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 63 more

    Contact details available

  • Carolyn Helms

    Venture Capital, Private Equity Firm · United States

    Health CareWearablesWomen FoundedLife Science

    Portfolio: Zavante Therapeutics, CardioDx, WelbeHealth, Velicept Therapeutics and 52 more

    Contact details available

  • Dayton Misfeldt

    Venture Capital · United States

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: Dermira, Phenomix, NuPathe, Cydan and 52 more

    Contact details available

  • Fred Craves

    Venture Capital · United States

    Health CareGeneticsWomen FoundedInvestment Management

    Portfolio: Dermira, Phenomix, NuPathe, Cydan and 52 more

    Contact details available

  • Hooman Shahlavi

    Hedge Fund, Venture Capital · United States

    Health CareGeneticsWomen FoundedInvestment Management

    Portfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 63 more

    Contact details available

  • Marc

    Venture Capital, Private Equity Firm · United States

    Health CareWearablesWomen FoundedLife Science

    Portfolio: Zavante Therapeutics, CardioDx, WelbeHealth, Velicept Therapeutics and 52 more

    Contact details available

  • Matt Kronmiller

    Venture Capital · United States

    Health CareGeneticsWomen FoundedInvestment Management

    Portfolio: Dermira, Phenomix, NuPathe, Cydan and 52 more

    Contact details available

  • Zander Liem

    Venture Capital · United States

    Health CareWearablesWomen FoundedLife Science

    Portfolio: Zavante Therapeutics, CardioDx, WelbeHealth, Velicept Therapeutics and 52 more

    Contact details available

  • carl goldfischer

    Venture Capital · United States

    Health CareGeneticsWomen FoundedInvestment Management

    Portfolio: Dermira, Phenomix, NuPathe, Cydan and 52 more

    Contact details available

  • Rob HopfnerVerified

    Venture Capital, Investor · United States

    SeedBiotechnologyPharmaceuticals

    Portfolio: Civitas Therapeutics, Inozyme, Rallybio

    Contact details available

Frequently asked questions

How many Civitas Therapeutics investors are on Angel Roster?

Angel Roster lists 26 Civitas Therapeutics investors. 13 of them (50%) include a verified email address.

What types of investors are they?

The most common investor types are Venture Capital Firms (26), Private Equity Firms (5) and Hedge Funds (2). An investor can have more than one type, for example an angel who is also a venture partner.

Which stages do Civitas Therapeutics investors invest in?

Among those that list a stage, the most common are Seed (11) and Series B (1).

Where are Civitas Therapeutics investors based?

Most are based in the United States (25) and Canada (1).

Which companies have Civitas Therapeutics investors backed?

The most-backed portfolio companies among them are Inozyme (21), Checkmate Pharmaceuticals (20), Vera Therapeutics (20), Neurana Pharmaceuticals (20) and Cydan (16).

How do I contact Civitas Therapeutics investors?

Create a free Angel Roster account to search and filter all 26, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.